Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/05/1996WO1996038166A1 Serum amyloid a protein
12/05/1996WO1996038165A2 Endoparasiticidal agents
12/05/1996WO1996038164A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996WO1996038163A1 Compositions containing an antibiotic and a peptide potentiating this antibiotic
12/05/1996WO1996038162A1 Method of using lectins for prevention and treatment of skin diseases and disorders
12/05/1996WO1996038161A1 Drug delivery enhancement via modified saponins
12/05/1996WO1996038139A1 Use of pyrrolidine derivatives for treating alcoholism
12/05/1996WO1996038136A1 Localized use of nitric oxide-adducts to prevent internal tissue damage
12/05/1996WO1996038130A1 Osmotic device with delayed activation of drug delivery and complete drug release
12/05/1996WO1996038115A1 Method of using lectins for agglutination and collection of menstrual flow
12/05/1996WO1996038093A2 Method for laser mediated tissue welding with enhanced strength
12/05/1996WO1996034966A3 Engineering protein posttranslational modification in transgenic organisms
12/05/1996WO1996034953A3 Cd16-ii variants
12/05/1996WO1996034884A3 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
12/05/1996WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
12/05/1996WO1996033691A3 Use of cgrp for treating hair loss
12/05/1996DE19520275A1 Endoparasitizide Mittel Endoparasiticides means
12/05/1996CA2741641A1 Antibody specific for a mammaglobin polypeptide
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2223063A1 Drug delivery enhancement via modified saponins
12/05/1996CA2222960A1 Imidazo 1,5a pyridine derived serine protease inhibitors
12/05/1996CA2222863A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996CA2222682A1 Composition to improve digestibility and utilisation of nutrients
12/05/1996CA2222655A1 Chemokine n-terminal deletion mutations
12/05/1996CA2222633A1 Method for laser mediated tissue welding with enhanced strength
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222599A1 Antimicrobial cationic peptides
12/05/1996CA2222419A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2220708A1 Serum amyloid a protein
12/05/1996CA2220530A1 Improved method for obtaining full-length cdna sequences
12/05/1996CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof
12/05/1996CA2217131A1 Modified cells and methods for inhibiting xenograft rejection
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745673A2 Catalytic antibody regulated prodrug therapy
12/04/1996EP0745612A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
12/04/1996EP0745611A1 Interleukin-4 and Interleukin-1beta synergistically induce VCAM-1
12/04/1996EP0745610A2 Process for preparing anti-obesity protein
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745131A1 Targeting gene therapy
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745125A1 Hematopoietic protein and materials and methods for making it
12/04/1996EP0745124A1 Mammalian cell cycle protein
12/04/1996EP0745123A1 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN
12/04/1996EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
12/04/1996EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745093A1 New oligopeptides with affinity to opioid receptors
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745091A1 Use of angiotensin ii analogs in tissue repair
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0744958A1 Polyclonal antibody libraries
12/04/1996EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0744955A1 Cyclic heptapeptide anti-inflammatory agent
12/04/1996EP0744954A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
12/04/1996EP0744953A1 Erythropoietin analog compositions and methods
12/04/1996EP0744952A1 Method for treating vascular obstructions caused by abnormal cells
12/04/1996EP0744949A1 Treatment and/or prevention of type i diabetes mellitus with gamma interferon administration
12/04/1996EP0744940A1 Drugs, vaccines and hormones in polylactide coated microspheres
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0744891A1 Transgenic fibrinogen
12/04/1996EP0578644B1 Antibiotic a 40926 ester derivatives
12/04/1996EP0485486B1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby
12/04/1996EP0480061B1 Hepatic disorder inhibitor
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996CN1137292A Purification of vitamin-K dependent proteins by membrane chromatography
12/04/1996CN1137273A Quinolizinone type compounds
12/04/1996CN1137064A Technique for producing water solution containing rich L-asparaginase
12/04/1996CN1137040A New mercaptoalanoyldipeptide compounds process for their preparation and pharmaceutical compositions containign them
12/04/1996CN1136961A Ointment for curing putrefactive wound, producing method and use thereof
12/04/1996CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels
12/03/1996US5581476 Computer-based methods and articles of manufacture for preparing G-CSF analogs
12/03/1996US5580984 Retroviral protease inhibiting compounds
12/03/1996US5580979 Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
12/03/1996US5580969 Antisense oligonucleotides directed against human ICAM-I RNA
12/03/1996US5580968 Useful in diagnosing and following the course of rheumatoid arthitis
12/03/1996US5580967 Optimized catalytic DNA-cleaving ribozymes
12/03/1996US5580963 Proteolysis resistance
12/03/1996US5580962 Purification of activated protein c by ion exchange chromatography to remove serum amyloid p, antibodies and thrombin-inhibitor complex, then inactivating viruses
12/03/1996US5580960 KS-laminin and methods of use
12/03/1996US5580957 Gonadotropin inhibitor
12/03/1996US5580956 Anticarcinogenic agents; bactericides
12/03/1996US5580955 Polypeptide
12/03/1996US5580954 Anti-obesity proteins
12/03/1996US5580953 Useful in therapy of type 2 diabetes mellitus, impaired glucose tolerance, obesity and insulin resistance
12/03/1996US5580903 Liver regeneration accelerator
12/03/1996US5580896 Treatment of pain and colorectal cancer with dipeptoids of α-substituted Trp-Phe derivatives
12/03/1996US5580876 Administering together with nalmefene; side effect reduction
12/03/1996US5580872 Administering in the treatment of bacterial infections
12/03/1996US5580862 Sulfated oligosaccharides as agonists treating inflammation
12/03/1996US5580856 Formulation of a reconstituted protein, and method and kit for the production thereof
12/03/1996US5580853 Erythropoietin with attached heterobifunctional crosslinking reagent containing cleavable disulfide bond group
12/03/1996US5580780 Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
12/03/1996US5580776 Having genetic material stably incorporated
12/03/1996US5580775 Excitatory amino acid neurotransmission in cns synapses
12/03/1996US5580774 Anticarcinogenic agents
12/03/1996US5580769 Antiviral protein secreted by peripheral blood lymphocytes which inhibits replication of retroviruses including human immunodeficiency virus
12/03/1996US5580768 Method for the production of proteins in plant fluids
1 ... 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 ... 3163